Literature DB >> 25951527

A cross-talk network that facilitates tumor virotherapy.

Agnieszka Bronisz1, E Antonio Chiocca1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25951527     DOI： 10.1038/nm.3857

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Phase ib trial of oncolytic herpes virus G207 shows safety of multiple injections and documents viral replication.

Authors:  Manish K Aghi; E Antonio Chiocca
Journal:  Mol Ther       Date:  2009-01       Impact factor: 11.454

2.  Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.

Authors:  Yasushi Kojima; Ahmet Acar; Elinor Ng Eaton; Kieran T Mellody; Christina Scheel; Ittai Ben-Porath; Tamer T Onder; Zhigang C Wang; Andrea L Richardson; Robert A Weinberg; Akira Orimo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 3.  Oncolytic viruses and their application to cancer immunotherapy.

Authors:  E Antonio Chiocca; Samuel D Rabkin
Journal:  Cancer Immunol Res       Date:  2014-04       Impact factor: 11.151

4.  Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

Authors:  Carolina S Ilkow; Monique Marguerie; Cory Batenchuk; Justin Mayer; Daniela Ben Neriah; Sophie Cousineau; Theresa Falls; Victoria A Jennings; Meaghan Boileau; David Bellamy; Donald Bastin; Christiano Tanese de Souza; Almohanad Alkayyal; Jiqing Zhang; Fabrice Le Boeuf; Rozanne Arulanandam; Lawton Stubbert; Padma Sampath; Steve H Thorne; Piriya Paramanthan; Avijit Chatterjee; Robert M Strieter; Marie Burdick; Christina L Addison; David F Stojdl; Harold L Atkins; Rebecca C Auer; Jean-Simon Diallo; Brian D Lichty; John C Bell
Journal:  Nat Med       Date:  2015-04-20       Impact factor: 53.440

Review 5.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

Review 6.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 7.  Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.

Authors:  Samuel T Workenhe; Karen L Mossman
Journal:  Mol Ther       Date:  2013-10-19       Impact factor: 11.454

Review 8.  The role of tumour-stromal interactions in modifying drug response: challenges and opportunities.

Authors:  Douglas W McMillin; Joseph M Negri; Constantine S Mitsiades
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

9.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

Review 10.  The host response to cancer virotherapy.

Authors:  E Antonio Chiocca
Journal:  Curr Opin Mol Ther       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.